Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study. This announcement marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback